Reducing the harms of xylazine: clinical approaches, research deficits, and public health context

• Published in: Harm reduction journal Vol. 20; no. 1; pp. 141 - 9
• Main Authors: Zagorski, Claire M., Hosey, Rebecca A., Moraff, Christopher, Ferguson, Aaron, Figgatt, Mary, Aronowitz, Shoshana, Stahl, Natalie E., Hill, Lucas G., McElligott, Zoe, Dasgupta, Nabarun
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 30.09.2023; BioMed Central; BMC
• Subjects: Anemia; Anesthesia; Benzodiazepines; Blood pressure; Case reports; Community involvement; Community participation; Complications and side effects; Dosage and administration; Drug injection; Drug withdrawal; Drugs; Epidemiology; Fatalities; Fentanyl; Harm Reduction; Health aspects; Heroin; Humans; Hyperglycemia; Hypertension; Management; Medical personnel; Methods; Narcotics; Poisoning; Public Health; Public participation; Reduction; Sex crimes; Surveillance; Veterinary drugs; Veterinary medicine; Wounds; Xylazine; Xylazine - therapeutic use; United States; Drug injection; Harm reduction; Wounds; Xylazine

Xylazine has emerged as a consistent part of the unregulated drug supply in recent months. We discuss major domains of xylazine's harm, current knowledge deficits, clinical and harm reduction strategies for minimizing harm, and xylazine's public health and policy context. As an interdiscip...